✦ LIBER ✦

Transcranial duplex in the differential diagnosis of parkinsonian syndromes

✍ Scribed by Annemarie M. M. Vlaar; Angela Bouwmans; Werner H. Mess; Selma C. Tromp; Wim E. J. Weber

Book ID: 106094268
Publisher: Springer
Year: 2009
Tongue: English
Weight: 208 KB
Volume: 256
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-009-0143-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The predictive value of transcranial dup

The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans

✍ Annemarie MM Vlaar; Tjerk de Nijs; Marinus JPG van Kroonenburgh; Werner H Mess; 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 240 KB

The role of cardiac metaiodobenzylguanid

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

✍ Stefan Braune 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 518 KB

Differential diagnosis of parkinsonian s

Differential diagnosis of parkinsonian syndromes: dynamics of time courses are essential

✍ Lachenmayer, L. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 194 KB

Differentiation of Parkinson's disease a

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound

✍ Behnke, S 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 70 KB

Anal sphincter EMG in the diagnosis of p

Anal sphincter EMG in the diagnosis of parkinsonian syndromes

✍ K. Winge; P. Jennum; A. Lokkegaard; L. Werdelin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Neurofilament heavy-chain NfHSMI35 in ce

Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes

✍ Johannes Brettschneider; Axel Petzold; Sigurd D. Süßmuth; Georg B. Landwehrmeyer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH^SMI35^ in the laboratory‐supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple‐system atrophy (MSA; n = 21), progress